IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Cerep Signs Deal with Sanofi-Aventis

10:26 AM MST | December 15, 2008 | Chemical Week Editorial Staff

Contract pharmaceutical ingredients manufacturer and pharmaceutical developer Cerep (Paris) says it has signed a drug license agreement with Sanofi-Aventis. The agreement relates to a drug for treating diabetes that was co-developed by the two companies. The drug is currently in pre-clinical trials. The licensing agreement triggers a milestone...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa